Shionogi (4507) Stock Price, Fundamentals & Analysis
Price
2,938 JPY
+0.7%
Last trade: Sep 25, 2026, 03:30 PM GMT+9
Updated: Sep 27, 2026, 06:31 PM GMT+9
Price history
Over the past year 4507 traded between 2,399 JPY and 3,664 JPY, closing at 2,938 JPY on Sep 25, 2026.
Key statistics
| Market cap | 2.5T JPY |
|---|---|
| P/E ratio (TTM) | 12.2 |
| Forward P/E | 15.4 |
| EPS (TTM) | 240.92 JPY |
| Dividend yield | 2.59% |
| Annual dividend | 76 JPY |
| Ex-dividend date | Sep 29, 2026 |
| Payout ratio | 29% |
| 52-week range | 2,392.5 – 3,758 |
| 52-week change | 13.6% |
| Beta | 0.03 |
| Price / book | 1.41 |
| Revenue (TTM) | 563.21B JPY |
| Revenue growth (YoY) | 63.7% |
| Gross margin | 82.1% |
| Operating margin | 11.4% |
| Profit margin | 46.8% |
| Return on equity | 16.8% |
| Debt / equity | 38.6 |
| Volume | 2,423,900 |
| Average volume | 2,639,026 |
| Next earnings | Oct 29, 2026 |
| Exchange | Tokyo |
Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 6,223
- Headquarters
- Kita, Japan
- Website
- shionogi.com
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.
Overview
What 4507 does
Shionogi (4507) is a stock listed on the Tokyo Stock Exchange in the Healthcare sector, specifically in the Drug Manufacturers – Specialty & Generic industry. The company researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It also operates in consumer healthcare, contract research services, and IT services for medical and healthcare-related issues. Shionogi is part of the Japanese equity landscape alongside peers such as Terumo (4543), Chugai Pharmaceutical (4519), Astellas (4503), and Sumitomo Dainippon Pharma (4506).
Key numbers explained
- Price: 2,938 JPY — the most recent trading price of one share.
- Trailing P/E ratio: 12.2 — the current share price divided by the last 12 months of earnings per share; a lower figure can suggest the stock is priced more conservatively relative to recent earnings.
- Forward P/E ratio: 15.4 — the price relative to expected future earnings, which incorporates analyst estimates of growth.
- Dividend yield: 2.59% — the annual dividend payment expressed as a percentage of the current share price.
- Ex-dividend date: Sep 29, 2026 — the date on or after which a buyer is no longer entitled to the next dividend payment.
- Beta: 0.03 — a measure of the stock’s sensitivity to overall market moves; a value close to zero suggests very low volatility relative to the market.
- 52-week range: 2,392.5 – 3,758 — the lowest and highest prices seen over the past year, showing the trading range.
- Revenue growth, year over year: 63.7% — the percentage increase in trailing 12-month revenue compared with the prior year.
What to watch
- The company’s profitMargin of 46.8% and operatingMargin of 11.4% show how much of each yen of revenue turns into profit and operating income.
- ReturnOnEquity of 16.8% indicates how efficiently the company uses shareholders’ equity to generate earnings.
- The debt-to-equity ratio of 38.6% reflects the balance between borrowed funds and equity financing.
- PriceToBook of 1.41 compares the market price to the company’s book value per share.
- The upcoming nextEarningsDate on Oct 29, 2026, is a key date for updated financial results.
- As a Healthcare stock, Shionogi (4507) can be influenced by drug development cycles, regulatory approvals, and broader healthcare policy changes.
Latest news & filings
No recent headlines.
Frequently asked questions
Does 4507 pay a dividend?
Yes. Shionogi (4507) has a dividend yield of 2.59%, with 29% of earnings paid out as dividends and an ex-dividend date of Sep 29, 2026.
What is the 4507 P/E ratio?
The trailing P/E ratio is 12.2, and the forward P/E ratio based on expected earnings is 15.4.
Where can I buy 4507?
Shionogi (4507) trades on the Tokyo Stock Exchange. You can buy it through any broker that provides access to Japanese equities.
How big is Shionogi?
The company has a market capitalisation of 2.5T JPY, 6,223 employees, and headquarters in Kita, Japan.
How volatile is 4507 compared to the market?
Its beta is 0.03, indicating very low sensitivity to overall market movements.
What has been the 52-week price performance?
The price has risen 13.6% over the last 52 weeks, within a range of 2,392.5 – 3,758 JPY.
Related
More on 4507
Track 4507 in your portfolio
Hold 4507 at XTB, IBKR, Tradeville, Revolut or Trading 212? InvestPane brings every broker into one dashboard — allocation, performance and dividends in one place.
Start free